Xeris Pharmaceuticals | XERS - Trade Creditors


Xeris Pharmaceuticals reported $3.08M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Celltrion KRW 104.19B 15.67B Sep/2025
Cspc Pharmaceutical CNY 2.32B 236.83M Dec/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 9.72M 3.02M Dec/2025
Divis Laboratories Ltd INR 10.4B 1.3B Sep/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Kangmei Pharma CNY 2.61B 176.42M Sep/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Organigram Holdings CAD 71.08M 18.17M Dec/2025
Ovoca Bio EUR 186K 23K Jun/2025
Pacira USD 15.15M 2.54M Dec/2025
Perrigo USD 474.5M 4.8M Dec/2025
Pharma Mar EUR 54.34M 10.54M Dec/2025
Qiagen NV USD 72.66M 2.11M Dec/2025
Sartorius EUR 345.3M 2.2M Mar/2026
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
Tilray USD 114.5M 3.69M Sep/2025
Zealand Pharma A/S 346.6M 102.71M Dec/2025
Zz Pientze Pharmaceu CNY 516.14M 31.53M Sep/2025